YIBO (YIBO) Stock Price & Analysis

YIBO (YIBO) rose 11.36% to USD 1 as of June 10, 2026 at 09:02 UTC, according to Nexqual real-time market data.

YIBO last closed at USD 0.9; the session ranged USD 0.89–1.04 on volume of 8,934 shares. Market capitalization is $59.21M, with a 52-week range of USD 0.63–1.82 (NCM). Source: Nexqual, June 10, 2026 at 09:02 UTC.

Key Statistics (as of June 10, 2026 at 09:02 UTC)

PriceUSD 1
Change▲ 11.36% (up)
Previous CloseUSD 0.9
OpenUSD 0.9
Day RangeUSD 0.89 – 1.04
52-Week RangeUSD 0.63 – 1.82
Volume8,934 shares
Market Cap$59.21M
ExchangeNCM

Technical Analysis (YIBO)

Nexqual's technical model rates YIBO "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 09:02 UTC.

Overall SignalSTRONG SELL
RSI (14)44.31 (neutral)
vs SMA50Above (USD 0.99)
MACD-0.01 (negative)

Analyst Ratings (YIBO)

Wall Street analysts rate YIBO "None", per Nexqual as of June 10, 2026 at 09:02 UTC.

Consensus RatingNone

Earnings (YIBO)

Source: Nexqual, June 10, 2026 at 09:02 UTC.

Financials & Fundamentals (YIBO)

Total Revenue$155.25M
Revenue Growth (YoY)+11.30%
Gross Margin+29.43%
Operating Margin-0.99%
Profit Margin-5.32%
ROE-14.38%
Debt / Equity93.94
Current Ratio1.58
Total Cash$54.41M
Total Debt$54.40M
Free Cash Flow$-2.49M

Source: Nexqual, June 10, 2026 at 09:02 UTC.

Financial Health Score (YIBO)

Nexqual rates YIBO's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:02 UTC.

GrowthSolid — Revenue +11% YoY (latest Q)
ProfitabilityWeak — Gross margin 29%, operating -1%
Balance SheetMixed — $54M cash vs $54M debt, net cash position
Cash FlowWeak — FCF negative: -$2M, burning cash
EfficiencyCritical — ROE -14%, ROA -4.8%

Ownership (YIBO)

Insider Ownership+85.94%
Institutional Ownership+0.22%
Shares Outstanding32.92M
Float7.13M
Short % of Float+0.35%

Source: Nexqual, June 10, 2026 at 09:02 UTC.

Leadership (YIBO)

YIBO is led by Shaofang Weng (age 54), CEO & Director, per Nexqual as of June 10, 2026 at 09:02 UTC.

CEO & DirectorShaofang Weng (age 54)
Founder & Chairman of the BoardWeidong Gu (age 55)
Chief Financial OfficerQuanmao Zhou (age 35)

Peers & Related Stocks

SymbolNamePriceChange
SLXNSilexion Therapeutics CorpUSD 4.17▼ 10.71%
JDZGJIADE LIMITEDUSD 50▲ 0%
SUGPSU Group Holdings LimitedUSD 1▲ 0.4%
ATPCAgape ATP CorporationUSD 3.12▲ 4.7%
HWHHWH International Inc.USD 1.23▲ 17.79%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:02 UTC. This page is informational and not investment advice.